Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy

NCT00951132 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Failure to include patients

Conditions

Depression

Interventions

DRUG: rosuvastatin
DRUG: Placebo

Sponsor

University Hospital, Akershus

Collaborators

[object Object]
[object Object]